Hypertrophic cardiomyopathy trials in Poland

1 of 5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• No phaseWithdrawn
  A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

  Where

  Katowice, Warsaw

  Age

  18 years and over

  People

  1,700 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT05489705